COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Epidemic Intelligence Service, CDC, Atlanta, GA, United States of America.
PLoS One. 2022 Mar 9;17(3):e0264085. doi: 10.1371/journal.pone.0264085. eCollection 2022.
Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before healthcare workers collected nasopharyngeal swab (NPS) samples on the same day. To characterize patient preferences for self-collection, this investigation explored ability, comfort, and ease of ANS and saliva self-collection for SARS-CoV-2 testing along with associated patient characteristics, including medical history and symptoms of COVID-19. With nearly all participants successfully submitting a specimen, favorable ratings from most participants (at least >79% in ease and comfort), and equivocal preference between saliva and ANS, self-collection is a viable SARS-CoV-2 testing option.
自我采集样本可以扩大 SARS-CoV-2 检测的范围。在一家大型市内医院，1082 名参与者在医护人员当天采集鼻咽拭子（NPS）样本之前，自行采集了唾液和前鼻拭子（ANS）样本。为了描述患者对自我采集的偏好，这项调查研究了自我采集用于 SARS-CoV-2 检测的 ANS 和唾液的能力、舒适度和便利性，以及与患者特征的相关性，包括医疗史和 COVID-19 症状。几乎所有参与者都成功提交了样本，大多数参与者（至少有 79%的人在便利性和舒适度方面）给出了良好的评价，而且在唾液和 ANS 之间存在模棱两可的偏好，因此自我采集是一种可行的 SARS-CoV-2 检测选择。
